These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3817231)

  • 1. [Studies on monoclonal antibodies to TSH receptors--heterogeneity and pathophysiological significance of antibodies to TSH receptor].
    Yoshida T
    Nihon Naibunpi Gakkai Zasshi; 1986 Dec; 62(12):1384-99. PubMed ID: 3817231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL; Erlanger BF
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to the thyrotropin receptor bind to a 56-kDa subunit of the thyrotropin receptor and show heterogeneous bioactivities.
    Yoshida T; Ichikawa Y; Ito K; Homma M
    J Biol Chem; 1988 Nov; 263(31):16341-7. PubMed ID: 2460448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
    Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of anti-TSH receptor antibodies in two patients who developed spontaneous hypothyroidism after antithyroid drug therapy for hyperthyroid Graves' disease.
    Kaise K; Kaise N; Yoshida K; Itagaki Y; Yamamoto M; Sakurada T; Saito S; Yoshinaga K
    Tohoku J Exp Med; 1987 Jul; 152(3):269-75. PubMed ID: 3660401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
    Abe Y
    Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves' disease.
    Macchia E; Fenzi GF; Monzani F; Bartalena L; Lippi F; Aloisio V; Cupini C; Baschieri L; Pinchera A
    J Endocrinol Invest; 1983 Oct; 6(5):375-8. PubMed ID: 6141201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
    Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
    Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of human-human hybridomas from patients with autoimmune thyroid disease.
    De Bernardo E; Davies TF
    J Clin Immunol; 1987 Jan; 7(1):71-7. PubMed ID: 3558736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor.
    Macchia E; Concetti R; Carone G; Borgoni F; Fenzi GF; Pinchera A
    Clin Endocrinol (Oxf); 1988 Feb; 28(2):147-56. PubMed ID: 2901922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways.
    Gilbert JA; Gianoukakis AG; Salehi S; Moorhead J; Rao PV; Khan MZ; McGregor AM; Smith TJ; Banga JP
    J Immunol; 2006 Apr; 176(8):5084-92. PubMed ID: 16585606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissues.
    Duh QY; Siperstein AE; Miller RA; Smeds S; Clark OH
    Surgery; 1989 Dec; 106(6):967-73; discussion 973-4. PubMed ID: 2588124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
    Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
    Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.
    Baker JR; Lukes YG; Burman KD
    J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.